Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study.
immunosuppression
keratinocyte cancer
solid organ transplant recipients
whole exome sequencing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Jun 2023
26 Jun 2023
Historique:
received:
22
05
2023
revised:
21
06
2023
accepted:
21
06
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Because of long-term immunosuppression, solid organ transplant recipients are at increased risk for keratinocyte cancer. We matched solid organ transplant patients (
Identifiants
pubmed: 37444464
pii: cancers15133354
doi: 10.3390/cancers15133354
pmc: PMC10340609
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Jubilee Fund of the Austrian National Bank Fond
ID : 17221
Organisme : Sanofi-Aventis GmbH Austria
ID : SGZ-2019-12574
Références
J Cell Biol. 2013 Dec 23;203(6):1063-79
pubmed: 24344185
Endocr Relat Cancer. 2008 Sep;15(3):787-99
pubmed: 18559958
J Cell Sci. 2011 Nov 15;124(Pt 22):3753-9
pubmed: 22114305
Transpl Int. 2019 Dec;32(12):1259-1267
pubmed: 31423648
Semin Cancer Biol. 2022 Aug;83:208-226
pubmed: 32717336
Nat Commun. 2020 Feb 10;11(1):820
pubmed: 32041948
Dermatol Surg. 2013 Mar;39(3 Pt 1):345-64
pubmed: 23190408
J Hematol Oncol. 2017 Jan 25;10(1):33
pubmed: 28122633
Biomedicines. 2018 Jan 02;6(1):
pubmed: 29301290
Cancer Lett. 2021 Feb 28;499:255-264
pubmed: 33242559
Front Cell Dev Biol. 2021 Apr 01;9:658865
pubmed: 33869225
Dev Cell. 2009 Nov;17(5):712-23
pubmed: 19922875
PLoS One. 2011;6(10):e25648
pubmed: 21998677
J Invest Dermatol. 2009 Sep;129(9):2142-7
pubmed: 19242514
Blood. 2009 Jun 11;113(24):6128-37
pubmed: 19190245
Nat Commun. 2016 Mar 11;7:10961
pubmed: 26965651
Exp Cell Res. 2019 Nov 15;384(2):111648
pubmed: 31562860
Front Immunol. 2018 Dec 03;9:2830
pubmed: 30559745
Lancet. 2007 Jul 7;370(9581):59-67
pubmed: 17617273
Clin Chem. 2004 Mar;50(3):490-9
pubmed: 14726470
Dev Cell. 2009 Nov;17(5):699-711
pubmed: 19922874
Ann Oncol. 2005 Jan;16(1):102-8
pubmed: 15598946
JAMA Dermatol. 2023 Jan 1;159(1):29-36
pubmed: 36416811
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2785-2792
pubmed: 29753811
J Am Acad Dermatol. 2018 Feb;78(2):237-247
pubmed: 29332704
Eur J Cancer. 2023 Mar;181:21-22
pubmed: 36628896
Immunology. 2019 Aug;157(4):312-321
pubmed: 31135971
Nat Commun. 2015 Apr 09;6:6825
pubmed: 25855136
Front Cell Dev Biol. 2019 Jul 03;7:110
pubmed: 31334230
Br J Dermatol. 2017 Nov;177(5):1208-1216
pubmed: 28994104
Nan Fang Yi Ke Da Xue Xue Bao. 2016 May;36(5):649-54
pubmed: 27222179
J Biol Chem. 2004 Aug 20;279(34):35958-66
pubmed: 15205466
Int J Cancer. 2006 Mar 1;118(5):1173-80
pubmed: 16161046
JAMA Dermatol. 2017 Mar 1;153(3):296-303
pubmed: 28097368
J Cancer Res Clin Oncol. 2022 Mar;148(3):547-564
pubmed: 35083552
Arch Dermatol. 1988 Jun;124(6):869-71
pubmed: 3377516
JCI Insight. 2020 May 21;5(10):
pubmed: 32434987
Br J Dermatol. 2019 Dec;181(6):1146-1155
pubmed: 30908599
Commun Biol. 2022 Apr 21;5(1):386
pubmed: 35449187
Cell Signal. 2018 Sep;49:1-16
pubmed: 29729335
Cancer Med. 2017 Jun;6(6):1389-1398
pubmed: 28485541
Nat Cell Biol. 2006 Dec;8(12):1383-8
pubmed: 17086175
Bioinformatics. 2016 May 1;32(9):1423-6
pubmed: 27153000
Histol Histopathol. 2023 Jun;38(6):681-693
pubmed: 36382967
Cancers (Basel). 2023 Jan 30;15(3):
pubmed: 36765822
Acta Biochim Biophys Sin (Shanghai). 2018 Jul 1;50(7):666-675
pubmed: 29860267
Mol Cell Biol. 2013 Mar;33(5):958-73
pubmed: 23275443
J Invest Dermatol. 2016 May;136(5):930-937
pubmed: 26829030
Med Sci Monit. 2019 May 07;25:3374-3389
pubmed: 31063460
FEBS J. 2019 Oct;286(19):3892-3908
pubmed: 31152622
Nat Commun. 2022 Oct 27;13(1):6385
pubmed: 36302784
Immunology. 2022 Jan;165(1):44-60
pubmed: 34716913
J Invest Dermatol. 2022 Feb;142(2):293-302.e1
pubmed: 34362555
Int J Cancer. 2013 Mar 15;132(6):1429-38
pubmed: 22886725
FEBS J. 2014 Dec;281(23):5237-50
pubmed: 25244576
Genes (Basel). 2021 Jul 19;12(7):
pubmed: 34356109
Mediators Inflamm. 2020 Jul 26;2020:3420946
pubmed: 32774142
Rev Environ Health. 2014;29(3):265-73
pubmed: 25252745
Br J Dermatol. 2017 Nov;177(5):1202-1207
pubmed: 28952162
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Cell Signal. 2014 Oct;26(10):2071-85
pubmed: 24949832
Eur J Immunol. 2011 Nov;41(11):3230-9
pubmed: 21805469
Acta Histochem. 2020 Sep;122(6):151576
pubmed: 32778238
Cell. 2011 Jan 21;144(2):253-67
pubmed: 21241894
FEBS Lett. 2015 Mar 12;589(6):756-65
pubmed: 25683004
J Proteomics. 2023 Apr 15;277:104863
pubmed: 36870673
Dermatol Surg. 2004 Apr;30(4 Pt 2):598-603
pubmed: 15061842
Prog Clin Biol Res. 1997;396:63-82
pubmed: 9108590
Int J Cancer. 2007 Oct 15;121(8):1729-37
pubmed: 17594688
Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1735-1745
pubmed: 35709760
Differentiation. 2007 Nov;75(9):770-87
pubmed: 17999740
Biochem Pharmacol. 2018 Sep;155:537-546
pubmed: 30031810
Oncotarget. 2016 Apr 12;7(15):20801-9
pubmed: 26989075
J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:33-37
pubmed: 31833604
Nature. 2021 Jan;589(7843):620-626
pubmed: 33408414
Front Oncol. 2021 Feb 18;10:564733
pubmed: 33680912
Pathol Oncol Res. 2006;12(2):87-91
pubmed: 16799709
PLoS One. 2014 Jun 02;9(6):e98606
pubmed: 24886983
Methods Mol Biol. 2016;1418:335-51
pubmed: 27008022
Am J Hum Genet. 2012 Aug 10;91(2):224-37
pubmed: 22863193
FEBS J. 2014 Feb;281(4):1068-84
pubmed: 24299491
Bioinformatics. 2021 Sep 29;37(18):3017-3018
pubmed: 33734315